Drug Profile
Research programme: inflammation and bacterial infection therapeutics - Bloom Burton and Co./Sirona Biochem
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Sirona Biochem - Bloom Burton & Co (JV)
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Inflammation
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Bacterial-infections in Canada
- 04 Nov 2017 No recent reports of development identified for research development in Inflammation in Canada
- 08 Oct 2013 Early research in Bacterial infections in Canada (unspecified route)